Hims & Hers Health Statistics
Total Valuation
HIMS has a market cap or net worth of $5.72 billion. The enterprise value is $5.48 billion.
Important Dates
The last earnings date was Monday, November 4, 2024, after market close.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HIMS has 218.48 million shares outstanding. The number of shares has increased by 9.52% in one year.
Current Share Class | 210.10M |
Shares Outstanding | 218.48M |
Shares Change (YoY) | +9.52% |
Shares Change (QoQ) | +0.12% |
Owned by Insiders (%) | 13.45% |
Owned by Institutions (%) | 69.99% |
Float | 189.08M |
Valuation Ratios
The trailing PE ratio is 58.94 and the forward PE ratio is 52.71.
PE Ratio | 58.94 |
Forward PE | 52.71 |
PS Ratio | 4.52 |
Forward PS | 2.81 |
PB Ratio | 12.97 |
P/TBV Ratio | 20.26 |
P/FCF Ratio | 35.57 |
P/OCF Ratio | 30.66 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 91.78, with an EV/FCF ratio of 34.06.
EV / Earnings | 54.13 |
EV / Sales | 4.41 |
EV / EBITDA | 91.78 |
EV / EBIT | 119.07 |
EV / FCF | 34.06 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.14 |
Quick Ratio | 1.69 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.18 |
Debt / FCF | 0.07 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 26.35% and return on invested capital (ROIC) is 7.33%.
Return on Equity (ROE) | 26.35% |
Return on Assets (ROA) | 5.66% |
Return on Capital (ROIC) | 7.33% |
Revenue Per Employee | $1.19M |
Profits Per Employee | $96,805 |
Employee Count | 1,046 |
Asset Turnover | 2.44 |
Inventory Turnover | 6.59 |
Taxes
Income Tax | -49.64M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +199.43% in the last 52 weeks. The beta is 1.25, so HIMS's price volatility has been higher than the market average.
Beta (5Y) | 1.25 |
52-Week Price Change | +199.43% |
50-Day Moving Average | 25.55 |
200-Day Moving Average | 19.26 |
Relative Strength Index (RSI) | 44.36 |
Average Volume (20 Days) | 16,745,326 |
Short Selling Information
The latest short interest is 42.62 million, so 19.51% of the outstanding shares have been sold short.
Short Interest | 42.62M |
Short Previous Month | 33.84M |
Short % of Shares Out | 19.51% |
Short % of Float | 22.54% |
Short Ratio (days to cover) | 1.73 |
Income Statement
In the last 12 months, HIMS had revenue of $1.24 billion and earned $101.26 million in profits. Earnings per share was $0.44.
Revenue | 1.24B |
Gross Profit | 1.01B |
Operating Income | 46.04M |
Pretax Income | 21.11M |
Net Income | 101.26M |
EBITDA | 59.72M |
EBIT | 46.04M |
Earnings Per Share (EPS) | $0.44 |
Full Income Statement Balance Sheet
The company has $254.07 million in cash and $11.36 million in debt, giving a net cash position of $242.71 million or $1.11 per share.
Cash & Cash Equivalents | 254.07M |
Total Debt | 11.36M |
Net Cash | 242.71M |
Net Cash Per Share | $1.11 |
Equity (Book Value) | 440.05M |
Book Value Per Share | 2.02 |
Working Capital | 173.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $186.68 million and capital expenditures -$25.77 million, giving a free cash flow of $160.92 million.
Operating Cash Flow | 186.68M |
Capital Expenditures | -25.77M |
Free Cash Flow | 160.92M |
FCF Per Share | $0.74 |
Full Cash Flow Statement Margins
Gross margin is 81.13%, with operating and profit margins of 3.71% and 8.15%.
Gross Margin | 81.13% |
Operating Margin | 3.71% |
Pretax Margin | 4.16% |
Profit Margin | 8.15% |
EBITDA Margin | 4.81% |
EBIT Margin | 3.71% |
FCF Margin | 12.96% |
Dividends & Yields
HIMS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.52% |
Shareholder Yield | -9.52% |
Earnings Yield | 1.77% |
FCF Yield | 2.81% |
Dividend Details Analyst Forecast
The average price target for HIMS is $23.71, which is -9.50% lower than the current price. The consensus rating is "Buy".
Price Target | $23.71 |
Price Target Difference | -9.50% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 31.90% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HIMS has an Altman Z-Score of 12.61 and a Piotroski F-Score of 5.
Altman Z-Score | 12.61 |
Piotroski F-Score | 5 |